These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 19793058)

  • 1.
    Hammond S; Thomson P; Meng X; Naisbitt D
    Front Immunol; 2021; 12():630530. PubMed ID: 33927714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides.
    Puig M; Ananthula S; Venna R; Kumar Polumuri S; Mattson E; Walker LM; Cardone M; Takahashi M; Su S; Boyd LF; Natarajan K; Abdoulaeva G; Wu WW; Roderiquez G; Hildebrand WH; Beaucage SL; Li Z; Margulies DH; Norcross MA
    Front Immunol; 2020; 11():629399. PubMed ID: 33633747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity.
    Copaescu A; Gibson A; Li Y; Trubiano JA; Phillips EJ
    Front Pharmacol; 2020; 11():573573. PubMed ID: 33597867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline on diagnostic procedures for suspected hypersensitivity to beta-lactam antibiotics: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Society of Allergology (AeDA), German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Austrian Society for Allergology and Immunology (ÖGAI), and the Paul-Ehrlich Society for Chemotherapy (PEG).
    Wurpts G; Aberer W; Dickel H; Brehler R; Jakob T; Kreft B; Mahler V; Merk HF; Mülleneisen N; Ott H; Pfützner W; Röseler S; Ruëff F; Sitter H; Sunderkötter C; Trautmann A; Treudler R; Wedi B; Worm M; Brockow K
    Allergol Select; 2020; 4():11-43. PubMed ID: 32568254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis.
    Cohan SL; Lucassen EB; Romba MC; Linch SN
    Biomedicines; 2019 Mar; 7(1):. PubMed ID: 30862055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Assays in Severe Cutaneous Adverse Drug Reactions: Are They Still Research Tools or Diagnostic Tests Already?
    Porebski G
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28796198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of In Vitro Tests to DiminishDrug Challenges.
    Mayorga C; Doña I; Perez-Inestrosa E; Fernández TD; Torres MJ
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.
    Peter JG; Lehloenya R; Dlamini S; Risma K; White KD; Konvinse KC; Phillips EJ
    J Allergy Clin Immunol Pract; 2017; 5(3):547-563. PubMed ID: 28483310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America.
    Torres MJ; Romano A; Celik G; Demoly P; Khan DA; Macy E; Park M; Blumenthal K; Aberer W; Castells M; Barbaud A; Mayorga C; Bonadonna P
    Clin Transl Allergy; 2017; 7():7. PubMed ID: 28293415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.
    Novais FO; Carvalho AM; Clark ML; Carvalho LP; Beiting DP; Brodsky IE; Carvalho EM; Scott P
    PLoS Pathog; 2017 Feb; 13(2):e1006196. PubMed ID: 28192528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.
    Whritenour J; Ko M; Zong Q; Wang J; Tartaro K; Schneider P; Olson E; Van Volkenburg M; Serrano J; Hayashi P; Fontana R; Chalasani N; Bonkovsky HL
    J Immunotoxicol; 2017 Dec; 14(1):31-38. PubMed ID: 28121193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostics of drug hypersensitivity reactions].
    Möbs C; Pfützner W
    Hautarzt; 2017 Jan; 68(1):19-28. PubMed ID: 28005146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro Models to Evaluate Drug-Induced Hypersensitivity: Potential Test Based on Activation of Dendritic Cells.
    Galbiati V; Papale A; Kummer E; Corsini E
    Front Pharmacol; 2016; 7():204. PubMed ID: 27462271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular in vitro diagnosis of adverse drug reactions.
    Möbs C; Pfützner W
    Allergo J Int; 2014; 23(5):164-171. PubMed ID: 26120528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology.
    Elzagallaai AA; Rieder MJ
    Br J Clin Pharmacol; 2015 Oct; 80(4):889-900. PubMed ID: 25199801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovered patients with Stevens-Johson syndrome and toxic epidermal necrolysis maintain long-lived IFN-γ and sFasL memory response.
    Fu M; Gao Y; Pan Y; Li W; Liao W; Wang G; Li C; Li C; Gao T; Liu Y
    PLoS One; 2012; 7(9):e45516. PubMed ID: 23029066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Orphanet J Rare Dis; 2010 Dec; 5():39. PubMed ID: 21162721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases.
    Zawodniak A; Lochmatter P; Yerly D; Kawabata T; Lerch M; Yawalkar N; Pichler WJ
    Allergy; 2010 Mar; 65(3):376-84. PubMed ID: 19793058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
    Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
    Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.